Peter S. Linder
Directeur/Membre du Conseil chez Molecular Detection, Inc.
Profil
In addition to serving as an Investment Committee Member for Emerald Stage2 Ventures, Mr. Linder is Chairman of the Executive Committee of the Mid-Atlantic Angel Group Fund, a member managed fund that bridges the gap between angel funding and institutional venture capital funding.
He was formerly Chairman of LORE, one of the oldest angel investment groups in the country.
He is also is a member of the Board of Directors of BFTP/SEP, and a member of the Advisory and Valuation Committees of Edison Venture Fund V.
He was recently elected to the Board of Directors of the Angel Capital Educational Foundation, a national organization devoted to education, information and research about angel investing.
Mr. Linder is Entrepreneur-in-Residence and a member of the faculty at Muhlenberg College.
He served for 10 years as a member of the Board of Directors of The Jackson Laboratory, a premier institution conducting basic research and providing resources in the field of genetics.
Mr. Linder also served 5 years as Chairman, Delaware County Hospital Authority.
Mr. Linder was Founder and President of Ethix, a managed care company operating HMOs and PPOs in 13 states, and grew the health plan membership to over 500,000.
He also founded American Interactive, a company specializing in hospital data processing systems.
He has a BSEE from Penn State University and an MSE from the University of Pennsylvania.
Postes actifs de Peter S. Linder
Sociétés | Poste | Début |
---|---|---|
Molecular Detection, Inc.
Molecular Detection, Inc. Medical SpecialtiesHealth Technology Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA. | Directeur/Membre du Conseil | 05/10/2009 |
Anciens postes connus de Peter S. Linder
Sociétés | Poste | Fin |
---|---|---|
Rittenhouse Ventures LLC
Rittenhouse Ventures LLC Investment ManagersFinance Rittenhouse Ventures LLC (Rittenhouse Ventures) is a venture capital firm founded in 2006 by Saul Richter and Bruce Luehrs. The firm is headquartered in Philadelphia, Pennsylvania. | Membre du Comité d'Investissement | - |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Corporate Officer/Principal | - |
Formation de Peter S. Linder
University of Pennsylvania | Graduate Degree |
The Pennsylvania State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Rittenhouse Ventures LLC
Rittenhouse Ventures LLC Investment ManagersFinance Rittenhouse Ventures LLC (Rittenhouse Ventures) is a venture capital firm founded in 2006 by Saul Richter and Bruce Luehrs. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Molecular Detection, Inc.
Molecular Detection, Inc. Medical SpecialtiesHealth Technology Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA. | Health Technology |